NEU neuren pharmaceuticals limited

two competition updates on Angelman and Prader Willi to follow:...

  1. 726 Posts.
    lightbulb Created with Sketch. 406
    two competition updates on Angelman and Prader Willi to follow:

    https://ir.ultragenyx.com/news-rele...pipeline-update-analyst-day-monday-october-16

    Panel discussion on GTX-102 for the treatment of Angelman syndrome (AS)
    • Elizabeth Berry-Kravis, M.D., Ph.D., Professor, Department of Pediatrics, RUSH Medical College, and principal investigator for GTX-102 Phase 1/2 study
    • Kemi Olugemo, M.D., F.A.A.N., vice president of global clinical development at Ultragenyx
    Elizabeth Berry-Kravis our old acquaintance!!!


    Then Harmony Biosciences (which is currently acquiring Zynerba Fragilex cannabinoids) updates us on Prader Willi:


    https://www.prnewswire.com/news-rel...nts-with-prader-willi-syndrome-301947886.html

    https://www.harmonybiosciences.com/...iences-to-acquire-zynerba-pharmaceuticals-inc
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.02
Change
-0.260(1.82%)
Mkt cap ! $1.745B
Open High Low Value Volume
$14.44 $14.44 $14.00 $3.454M 245.0K

Buyers (Bids)

No. Vol. Price($)
10 7440 $14.00
 

Sellers (Offers)

Price($) Vol. No.
$14.11 3159 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.